Alexander disease: models, mechanisms, and medicine. (February 2022)

• Record Type: Journal Article
• Authors: Hagemann, Tracy L.
• Is Part Of: Current opinion in neurobiology. Volume 72(2022)
• Page Start: 140
• Page End: 147
• Publication Date: 2022-02
• Subjects: Neurobiology -- Periodicals; 573.8
• DOI: 10.1016/j.conb.2021.10.002
• Languages: English
• ISSNs: 0959-4388

Abstract

Abstract: Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment.